Physician profile
Amy Lee
NPI 1215710033
$2,393.74
in general payments reported to CMS, 2019-2025
15 companies · $1,518 in 2025
The $1,518 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $876 · 2025: $1,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,379 · Travel and Lodging: $14.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,379.49 |
| Travel and Lodging | $14.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $255.07 | 2024-2025 | Proclaim |
| Nevro Corp. | $255.07 | 2024 | Senza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $234.69 | 2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $228.51 | 2024 | Voquezna |
| Scpharmaceuticals INC. | $149.66 | 2025 | Furoscix |
| Supernus Pharmaceuticals, INC. | $147.85 | 2024 | Qelbree |
| Alnylam Pharmaceuticals INC. | $137.90 | 2025 | Onpattro |
| Amgen INC. | $135.96 | 2024 | |
| Sanofi US Services INC. | $132.10 | 2025 | |
| Janssen Pharmaceuticals, INC | $125.31 | 2025 | Invega Sustenna |
| Novo Nordisk INC | $125.01 | 2025 | |
| Genzyme Corporation | $122.80 | 2025 | |
| Lilly USA, LLC | $116.15 | 2025 | Zepbound |
| Axsome Therapeutics, INC. | $115.32 | 2025 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $112.34 | 2025 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.